1-11 of 11
Paulo Lúcio
Close
Sort by
Journal Articles

Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study

Maria-Victoria Mateos, Jesús San-Miguel, Michele Cavo, Joan Bladé Creixenti, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lucio, Zsolt Nagy, Ludek Pour, Sebastian Grosicki, Andre H Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung-Soo Yoon, Genadi Iosava, Tomoaki Fujisaki, Mamta Garg, Huiling Pei, Maria Krevvata, Robin Carson, Fredrik Borgsten, Meletios A. Dimopoulos
Journal: Blood
Blood (2022) 140 (Supplement 1): 10157–10159.
https://doi.org/10.1182/blood-2022-163347
Published: 2022
Journal Articles

Long-Term Outcomes and Health-Related Quality of Life (HRQoL) By Response Status for Bortezomib, Melphalan, and Prednisone (VMP) ± Daratumumab (DARA) in Alcyone

Paula Rodriguez-Otero, Mario Boccadoro, Roman Hajek, MD, Tomoaki Fujisaki, MD, Jae Hoon Lee, MD PhD, Joaquin Martinez-Lopez, MD, Paulo Lucio, MD PhD, Zsolt Nagy, MD PhD, Ganna Usenko, MD, Anna Marina Liberati, MD, Mihaela Lazaroiu, MD, Dariusz Woszczyk, MDPhD, Hiroyuki Takamatsu, MDPhD, Joanna Romejko-Jarosinska, Stefan Tobias Knop, Astrid Pavlovsky, MD, Cecily Forsyth, FRACP, FRCPA, MBBS, Takayuki Ishikawa, MD PhD, Katharine S. Gries, PhD PharmD, Huiling Pei, PhD, Anupa Kudva, MD, Jon Ukropec, PhD, Susan Wroblewski, PhD, Robin Carson, MD BA, Meletios A Dimopoulos
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-136145
Published: 2020
Journal Articles

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone

Maria-Victoria Mateos, Michele Cavo, Joan Bladé, MD PhD, Meletios A. Dimopoulos, MD, Kenshi Suzuki, MD PhD, Andrzej Jakubowiak, MD PhD, Stefan Knop, Chantal Doyen, MD, Paulo Lucio, MD PhD, Zsolt Nagy, MD PhD, Ludek Pour, MD, Mark Cook, MBChB,PhD, Sebastian Grosicki, MD PhD, Andre H Crepaldi, MD, Anna Marina Liberati, Philip Campbell, MBBS, FRACP, FRCPA, Tatiana Shelekhova, Sung-Soo Yoon, MD PhD, Genadi Iosava, MD, Tomoaki Fujisaki, MD PhD, Mamta Garg, MD FRCP, FRCPath, Maria Krevvata, PhD, Jianping Wang, Anupa Kudva, MD, Jon Ukropec, PhD, Susan Wroblewski, PhD, Rachel Kobos, MD, Jesús San-Miguel
Journal: Blood
Blood (2019) 134 (Supplement_1): 859.
https://doi.org/10.1182/blood-2019-123401
Published: 2019
Journal Articles

One-Year Update of a Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Patients (Pts) with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Alcyone

Meletios A Dimopoulos, MD, Maria-Victoria Mateos, MD PhD, Michele Cavo, MD, Kenshi Suzuki, MD PhD, Andrzej Jakubowiak, MD PhD, Stefan Knop, Chantal Doyen, MD, Paulo Lucio, Zsolt Nagy, MD PhD, Polina Kaplan, Ludek Pour, MD, Mark Cook, MBChB,PhD, Sebastian Grosicki, MD PhD, Andre H Crepaldi, MD, Anna Marina Liberati, MD, Philip Campbell, MBBS, FRACP, FRCPA, Tatiana Shelekhova, Sung-Soo Yoon, MD PhD, Genadi Iosava, MD, Tomoaki Fujisaki, MD PhD, Mamta Garg, Christopher Chiu, PhD, Jianping Wang, Anupa Kudva, Rachel Kobos, MD, Susan Wroblewski, PhD, Ming Qi, MD PhD, Jesus F San-Miguel, MD PhD, Joan Bladé, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 156.
https://doi.org/10.1182/blood-2018-156
Published: 2018
Journal Articles

Predicting Early Mortality in Multiple Myeloma Patients Treated with Novel Agents

Catarina Geraldes, MD PhD, Adriana Roque, MD, Ana Bela Sarmento-Ribeiro, MD PhD, Maria Leticia Ribeiro, MD PhD, Rui Bergantim, MD, Fernanda Trigo, MD, Sérgio Chacim, MD, Ana Macedo, Carolina Viveiros, Cristina Joao, MD PhD MSc, Manuel Neves, MD, Paulo Lucio
Journal: Blood
Blood (2018) 132 (Supplement 1): 5641.
https://doi.org/10.1182/blood-2018-99-117351
Published: 2018
Journal Articles

Characterization of Circulating and Bone Marrow Derived Exosomes in Multiple Myeloma Patients

Bruna Velosa Ferreira, MD, Paulo Lucio, MD PhD, Manuel Neves, MD, Antonio Parreira, MD PhD, Bruno Costa-Silva, PhD, Cristina Joao, MD PhD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3172.
https://doi.org/10.1182/blood-2018-99-117656
Published: 2018
Journal Articles

Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible for Transplant (ALCYONE)

Maria-Victoria Mateos, Meletios A. Dimopoulos, Michele Cavo, MD, Kenshi Suzuki, Andrzej J. Jakubowiak, MD, Stefan Knop, MD, Chantal Doyen, MD, Paulo Lucio, Zsolt Nagy, MD PhD, Polina Kaplan, Ludek Pour, Doc,MD PhD, Mark Cook, MBChB,PhD, Sebastian Grosicki, MD PhD, Andre H Crepaldi, MD, Anna Marina Liberati, Philip Campbell, MBBS, FRACP, FRCPA, Tatiana Shelekhova, Sung-Soo Yoon, MD PhD, Genadi Iosava, Tomoaki Fujisaki, MD, Mamta Garg, MD, Christopher Chiu, PhD, Jianping Wang, Robin Carson, MD BA, Wendy Crist, BA, William Deraedt, Marie Nguyen, Ming Qi, Jesus F. San-Miguel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): LBA-4.
https://doi.org/10.1182/blood.V130.Suppl_1.LBA-4.LBA-4
Published: 2017
Journal Articles

Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia

Leila R. Martins, Paulo Lúcio, Milene C. Silva, Kenna L. Anderes, Paula Gameiro, Maria G. Silva, João T. Barata
Journal: Blood
Blood (2010) 116 (15): 2724–2731.
https://doi.org/10.1182/blood-2010-04-277947
Published: 2010
Includes: Supplemental data
Journal Articles

Flow Cytometric Detection of BCR-ABL Fusion Proteins in Leukemia Patients Via An Immunobead Assay

Floor Weerkamp, E. Dekking, Vincent H.J. Van der Velden, Sebastian Böttcher, Nancy Boeckx, Elisabeth R. Van Wering, Juan Flores Montero, Paulo Lucio, Lukasz Sedek, Tomas Kalina, Elizabeth Macintyre, Frank J.T. Staal, Jacques JM van Dongen, Ph.D
Journal: Blood
Blood (2008) 112 (11): 2533.
https://doi.org/10.1182/blood.V112.11.2533.2533
Published: 2008
Journal Articles

Differential Effects of Delta1 and Jagged1 in Early Human Myelopoiesis: Correlation with Distinct Gene-Expression Profiles in CD34 + Cells.

Hélia Neves, Floor Weerkamp, Brigitta A.E. Naber, Paula Gameiro, PhD, Jörg D. Becker, PhD, Paulo Lucio, PhD, Nuno Clode, Jacques J.M. van Dongen, PhD, Frank J.T. Staal, PhD, Leonor Parreira, PhD
Journal: Blood
Blood (2004) 104 (11): 2786.
https://doi.org/10.1182/blood.V104.11.2786.2786
Published: 2004
Journal Articles

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value

Clinical Trials & Observations
María-Belén Vidriales, José J. Pérez, Maria Consuelo López-Berges, Norma Gutiérrez, Juana Ciudad, Paulo Lucio, Lourdes Vazquez, Ramón García-Sanz, Maria Consuelo del Cañizo, Javier Fernández-Calvo, Fernando Ramos, M. Jesús Rodríguez, M. José Calmuntia, Ana Porwith, Alberto Orfao, Jesús F. San-Miguel
Journal: Blood
Blood (2003) 101 (12): 4695–4700.
https://doi.org/10.1182/blood-2002-08-2613
Published: 2003